Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone levels and reproductive outcomes in HRT-FET cycles
ChiCTR2500098162Phase 4Not yet recruiting
- Sponsor
- Chongqing Health Center for Women and Children
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of progesterone and dydrogesterone in infertility, sponsored by Chongqing Health Center for Women and Children. Primary endpoint: Serum progesterone level on the day of embryo transfer. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
progesteronedydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2500098162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098162.